InMed Pharmaceuticals Inc (INM)

NASDAQ HEALTHCARE
$1.57 -6.55% RSI 73 Overbought Add Alert

Moving Averages

SMA 200
$1.45
Price above

Company Profile

InMed Pharmaceuticals Inc., a clinical-stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company is headquartered in Vancouver, Canada.

Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market Cap
$2.06M
P/E Ratio
None
EPS
$-2.88
Beta
0.574
Dividend Yield
0.00%
52-Week High
$5.5
52-Week Low
$0.575

Similar stocks in DRUG MANUFACTURERS - SPECIALTY & GENERIC

HIMS
Hims & Hers Health Inc - Class A
RSI 60.0
CGC
Canopy Growth Corporation
RSI 50.0
BFRI
Biofrontera Inc
RSI 44.0
TLRY
Tilray Brands Inc - Class 2
RSI 43.0
LNTH
Lantheus Holdings Inc
RSI 59.0
ACB
Aurora Cannabis Inc
RSI 57.0
BCRX
Biocryst Pharmaceuticals Inc
RSI 44.0
ORGO
Organogenesis Holdings Inc - Class A
RSI 52.0
ZTS
Zoetis Inc - Class A
RSI 57.0
AQST
Aquestive Therapeutics Inc
RSI 52.0

Data last updated: May 13, 2026 at 6:31 AM EDT

Track INM for free

Get e-mail RSI alerts when InMed Pharmaceuticals Inc enters oversold or overbought territory. Free forever.

Add Alert